Efficacy of the PD-1 inhibitor penpulimab in combination with chemotherapy for advanced lung squamous cell carcinoma: insights from a phase III multicenter study.

ABSTRACT:

SUBMITTER: Yamaguchi F 

PROVIDER: S-EPMC11833557 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature